[Endocarditis prophylaxis in children and adolescents : implementation of the current guidelines in the Department of Paediatric Surgery at the Medical University Graz].
The timely administration of endocarditis prophylaxis means an additional stress situation for many children and their parents in an already stressful preoperative period. In addition it causes an increased organizational effort most of all in the day care department. Over many decades the use of prophylactic antibiotics to prevent infective endocarditis was recommended in patients with underlying cardiac conditions undergoing medical procedures which could lead to bacteraemia. However, transient bacteraemia occurs commonly during routine daily activities such as cleaning teeth or chewing. Most cases of endocarditis are not related to a medical procedure. There are currently no randomized and carefully controlled human trials to definitely prove the effectiveness and efficiency of endocarditis prophylaxis. Therefore, the new guidelines recommend the use of antibiotic prophylaxis only for cardiac conditions associated with the highest risk of adverse outcome from endocarditis. In paediatric surgery and paediatric anaesthesiology this applies mainly to patients with congenital heart disease. The implementation of the new guidelines in the Department of Paediatric Surgery at the Medical University Graz is illustrated in the following article.
Vittinghoff
M
M
Universitätsklinik für Anästhesiologie und Intensivmedizin, Medizinische Universität Graz, Auenbruggerplatz 29, 8036 Graz, Osterreich. maria.vittinghoff@medunigraz.at
Gutmann
A
A
Messerer
B
B
Nagl
B
B
Toller
W
W
D000293:Adolescent; D019072:Antibiotic Prophylaxis; D016470:Bacteremia / Q000517:prevention & control; D002648:Child; D004697:Endocarditis, Bacterial / Q000517:prevention & control*; D019983:Guideline Adherence; D017408:Guidelines as Topic; D006330:Heart Defects, Congenital / Q000150:complications; D006801:Humans; D011183:Postoperative Complications / Q000517:prevention & control*; D018570:Risk Assessment
Arch Intern Med. 1992 Sep;152(9):1869-73
1520053
Med Decis Making. 2005 May-Jun;25(3):308-20
15951458
JAMA. 1997 Jun 11;277(22):1794-801
9178793
Eur Heart J. 2009 Oct;30(19):2369-413
19713420
JAMA. 2002 Jul 3;288(1):75-81
12090865
Heart. 2005 Jun;91(6):715-8
15894758
Circulation. 2004 Jun 15;109(23):2878-84
15173031
Clin Infect Dis. 2008 Nov 15;47(10):1287-97
18834314
Pediatrics. 2004 May;113(5):1291-6
15121944
Infect Dis Clin North Am. 1999 Dec;13(4):833-50, vi
10579111
Pediatr Cardiol. 1997 Jan-Feb;18(1):24-7
8960488
Circulation. 2007 Oct 9;116(15):1736-54
17446442
Eur Heart J. 1995 Mar;16(3):394-401
7789383
Lancet Infect Dis. 2008 Apr;8(4):225-32
18353264
J Antimicrob Chemother. 2006 Jun;57(6):1035-42
16624872
Circulation. 2008 Jun 17;117(24):3118-25
18541739
Heart. 2006 Sep;92(9):1274-7
16488926
J Clin Periodontol. 2006 Jun;33(6):401-7
16677328
Clin Infect Dis. 2006 Jun 15;42(12):e102-7
16705565
Anaesthesist. 2008 Jun;57(6):613-5
18463836
Infect Dis Clin North Am. 1993 Mar;7(1):9-19
8463656